[London, UK] Partners4Access (P4A) is proud to announce the launch of its new Digital Solutions, designed to revolutionize how pharmaceutical companies approach product launches in the rare disease space. This suite of solutions includes three key components aimed at optimizing the success of global launches.
RarePulse™ is a powerful omnichannel listening service that enables real-time insights across digital platforms, providing a deep understanding of the patient and healthcare provider ecosystem. We have access to more than two million digital channels and data in 180 languages. Coupled with our market access expertise, this service helps companies track sentiment, engagement, and market trends, ensuring insight-driven decisions are at the core of launch strategies. This is a cost-effective and efficient way of gathering data on clinician perspectives, patient perception and experience.
The Digital Launch Platform offers a fully customized platform that streamlines and centralizes the entire launch process for global launches across multiple affiliate and distributor teams. Housing all the key steps and resources necessary for a successful product launch, this platform ensures seamless and consistent execution from planning to post-launch analysis.
Our Launch Success Model provides a dynamic, global view for optimizing launch strategies. Combining analogue-based asset valuation, dynamic launch sequence modelling and net-present value dashboards, the model helps companies navigate the complexities of global markets and adjust strategies for maximum impact.
P4A will be showcasing these innovative services at the World Orphan Drug Congress in Barcelona, from October 21-25, 2024. Attendees are encouraged to visit our booth to learn more about how Digital Solutions can drive successful global product launches.
“We are excited to bring our Digital Solutions to the market at such a prestigious event. With RarePulse™, the Digital Launch Platform, and the Launch Success Model, we’re equipping companies with the tools they need to thrive in an increasingly complex and competitive landscape,” said Darren Callanan, Global Digital Lead at P4A
For more information on Digital Solutions or to schedule a demonstration at the World Orphan Drug Congress, please visit partners4access.com or contact dcallanan@partners4access.com.
About Partners4Access
Partners4Access (P4A) is a global consultancy specializing in market access for orphan drugs, gene therapies, and other rare disease treatments. P4A’s expertise lies in navigating the unique challenges of launching and accessing innovative therapies, helping clients bring life-saving treatments to patients around the world. With a team of experienced professionals, P4A provides tailored solutions to optimize pricing, reimbursement, and market access strategies